GlassScriptPhysician profile
Luis C Grau
NPI 1710220090
$52,878.31
in general payments reported to CMS, 2019-2025
33 companies · $849 in 2025
The $849 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,981 · 2020: $849 · 2021: $8,313 · 2022: $18K · 2023: $18K · 2024: $3,210 · 2025: $849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,320 · Food and Beverage: $3,242 · Travel and Lodging: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,300.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,320.00 |
| Food and Beverage | $3,242.44 |
| Travel and Lodging | $654.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $31,742.96 | 2019-2025 | Triathlon, Mako, Accolade |
| Smith+Nephew, INC. | $17,936.33 | 2020-2025 | Real Intelligence, Polarstem, Journey II |
| Seapearl East, INC | $1,217.71 | 2021 | |
| Depuy Synthes Sales INC. | $382.50 | 2019-2024 | Orthovisc, Monovisc |
| Nuvasive, INC. | $225.71 | 2019 | |
| Ferring Pharmaceuticals INC. | $139.02 | 2019-2024 | Euflexxa |
| Ortho Development Corporation | $128.03 | 2019 | |
| Boston Scientific Corporation | $127.80 | 2024 | Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $118.87 | 2019 | |
| Zimmer Biomet Holdings, INC. | $107.58 | 2024 | |
| Davol INC. | $103.17 | 2021 | |
| Gilead Sciences, INC. | $74.32 | 2020 | |
| Horizon Therapeutics Plc | $69.63 | 2019-2022 | |
| Medtronic, INC. | $46.32 | 2022 | |
| Trevena, INC. | $45.06 | 2023 | Olinvyk |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $42.01 | 2025 | Reactiv8 |
| Avanos Medical | $39.22 | 2021-2022 | |
| Bioventus LLC | $37.78 | 2020-2022 | |
| Vertex Pharmaceuticals Incorporated | $36.22 | 2025 | |
| Conmed Corporation | $31.45 | 2024 | Abc Handpieces, System 2450 |
| Pacira Therapeutics, INC. | $25.41 | 2019 | |
| Linkbio Corp | $23.75 | 2025 | |
| Royal Biologics, INC. | $21.34 | 2022 | |
| Heron Therapeutics, INC. | $20.50 | 2025 | Zynrelef |
| Sanofi-Aventis U.S. LLC | $19.60 | 2023 | |
| Sanara Medtech INC. | $18.97 | 2025 | Biasurge |
| Glaxosmithkline, LLC. | $16.29 | 2024 | Trelegy Ellipta |
| Fidia Pharma USA INC. | $15.56 | 2020 | |
| Ethicon US, LLC | $15.43 | 2025 | Stratafix |
| Pacira Pharmaceuticals Incorporated | $14.62 | 2022 | |
| Abbott Laboratories | $13.89 | 2023 | Proclaim |
| Kowa Pharmaceuticals America, INC. | $12.10 | 2022 | |
| Heraeus Medical, LLC. | $9.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Grau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.